Can PET/CT scans improve Follow-Up for anal cancer patients?
NCT ID NCT02697084
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study followed 110 people with anal cancer to see if PET/CT scans can help doctors monitor the disease after initial treatment. Researchers tracked how long patients stayed cancer-free and measured metabolic activity in tumors. The goal is to find better ways to detect relapses early, since current follow-up methods lack strong evidence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors use PET/CT scans to better track anal cancer after treatment, potentially catching relapses earlier.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks at how well PET/CT works for follow-up, so it won't directly improve survival or cure the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL CANAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine Lacassagne
Nice, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an immunotherapy drug boost the power of chemoradiation against anal cancer?
- Can anal cancer treatment spare sexual well-being? a study tracks the toll over two years.
- HIV and cancer: study seeks to uncover hidden risk factors
- What do gay men know about anal cancer screening? a new survey aims to find out
- New drug combo targets HPV-Driven cancers in phase II trial
- Vitamins e and CoQ10 tested as shield against radiation damage